The effect of rosuvastatin on platelet-leukocyte interactions in the setting of acute coronary syndrome

Travis R. Sexton, Eric L. Wallace, Tracy E. Macaulay, Richard J. Charnigo, Virgilio Evangelista, Charles L. Campbell, Alison L. Bailey, Susan S. Smyth

Research output: Contribution to journalLetterpeer-review

12 Scopus citations
Original languageEnglish
Pages (from-to)306-307
Number of pages2
JournalJournal of the American College of Cardiology
Volume65
Issue number3
DOIs
StatePublished - Jan 27 2015

Bibliographical note

Funding Information:
Please note: This work was supported by an investigator-initiated grant from AstraZeneca . Additional support was provided by the National Center for Research Resources and the National Center for Advancing Translational Sciences , National Institutes of Health , through Grant UL1TR000117. Dr. Sexton was supported in part by T32HL091812 from the Heart Lung and Blood Institute , National Institutes of Health . Dr. Charnigo has been a coinvestigator with Dr. Smyth on 2 grants from AstraZeneca . Dr. Bailey has received grant support from AstraZeneca . Dr. Smyth has previously served on advisory boards for AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Funding

Please note: This work was supported by an investigator-initiated grant from AstraZeneca . Additional support was provided by the National Center for Research Resources and the National Center for Advancing Translational Sciences , National Institutes of Health , through Grant UL1TR000117. Dr. Sexton was supported in part by T32HL091812 from the Heart Lung and Blood Institute , National Institutes of Health . Dr. Charnigo has been a coinvestigator with Dr. Smyth on 2 grants from AstraZeneca . Dr. Bailey has received grant support from AstraZeneca . Dr. Smyth has previously served on advisory boards for AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

FundersFunder number
National Institutes of Health (NIH)T32HL091812
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Research Resources
AstraZeneca
National Center for Advancing Translational Sciences (NCATS)UL1TR000117

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'The effect of rosuvastatin on platelet-leukocyte interactions in the setting of acute coronary syndrome'. Together they form a unique fingerprint.

    Cite this